Background: Acute lower limb ischemia (ALLI) poses a major threat to limb survival. For many years, surgical thromboembolectomy was the mainstay of treatment. Recent years have brought an endovascular revolution to the management of ALLI. It seems that the newly designed endovascular thrombectomy devices may shift treatment recommendations toward endovascular options. This protocol study aims to collect evidence supporting the latest hypothesis. Objective: The devices under investigation are the Penumbra/Indigo Systems (Penumbra Inc). The objective of this clinical investigation is to evaluate, in a controlled setting, the early safety and effectiveness of the devices and to define the optimal technique for the use of these systems in patients with confirmed peripheral acute occlusions. Methods: This study will be an interventional prospective trial of patients with a diagnosis of ALLI treated with Penumbra/Indigo devices. This project is intended to be a national platform where every physician invited to participate could register his or her own data procedure. The primary outcome is the technical success of thromboaspiration with the Indigo System. Assessment of vessel patency will be recorded using the Thrombolysis in Myocardial Infarction (TIMI) score classifications before and after use of the device. Clinical success at follow-up is defined as an improvement of Rutherford classification at 1-month follow-up of one class or more as compared to the preprocedure Rutherford classification. Secondary endpoints include the following: (1) safety rate at discharge, defined as the absence of any serious adverse events; (2) primary patency at 1 month, defined as a target lesion without a hemodynamically significant stenosis or reocclusion on duplex ultrasound (>50%) and without target lesion reintervention within 1 month; and (3) limb salvage at 1 month. Results: The study is currently in the recruitment phase and the final patient is expected to be treated by the end of March 2019. A total of 150 patients will be recruited. Analyses will focus on primary and secondary endpoints. Conclusions: These new endovascular thrombectomy devices that are specifically designed for peripheral intervention in this difficult set of patients, as those under investigation in the proposed registry, may offer improved clinical outcomes with lower rates of major systemic and local complications. Following completion of this study, it is expected that the value of the Indigo Thrombectomy System in the treatment of ALLI will be better defined. As a result, a shift of treatment recommendations toward endovascular options may be observed in the near future.

The Indigo System in acute lower-limb malperfusion (INDIAN) registry. Protocol / de Donato, Gianmarco; Pasqui, Edoardo; Giannace, Giovanni; Setacci, Francesco; Benevento, Domenico; Palasciano, Giancarlo; Setacci, Carlo; Registry Collaborators, Indian; Ercolini, Leonardo; Pieraccini, Massimo; Galzerano, Giuseppe; Michelagnoli, Stefano; Chisci, Emiliano; Troisi, Nicola; Rossato, Denis; Ruffino, Antonella; Di Scalzi, Andrea; Mancini, Andrea; Nessi, Franco; Gaggiano, Andrea; Ferri, Michelangelo; Viazzo, Andrea; Savio, Daniele; di Maggio, Luca; Comelli, Chiara; Natrella, Massimiliano; Palombo, Domenico; Giovanni, Spinella; Pratesi, Giovanni; Pane, Bianca; Spinazzola, Angelo; Arzini, Aldo; Boccalon, Luca; Guzzardi, Giuseppe; Cuomo, Raffaele; Ravanelli, Marco; Bonera, Massimiliano; Quaretti, Pietro; Moramarco, Lorenzo; Cionfoli, Nicola; Pirrelli, Stefano; Cariati, Maurizio; Santuari, Davide; Carrafiello, Gianpaolo; Rampoldi, Antonio; Luca Canu, Gian; Sponza, Massimo; Gorgatti, Tommaso; Jannello, Antonio; Garriboli, Luca; Speziale, Francesco; Mansour, Wassim Ahmad; Sirignano, Pasqualino; Lenti, Massimo; Isernia, Giacomo; Simonte, Gioele; Ippoliti, Arnaldo; Citoni, Gianluca; Veroux, Pierfrancesco; Giaquinta, Alessia; Cappiello, Pierluigi; Esposito, Andrea; Intrieri, Francesco; Perri, Paolo; Molinari, Vincenzo; Esposito, Antonio; Pestrichella, Vincenzo; Patanè, Domenico; Gianpalma, Emanuela; Freyrie, Antono; Palmarini, Domenico; Silingardi, Roberto; Lauricella, Antonio; Stella, Andrea; Gargiulo, Mauro; Pulli, Raffaele; Marinazzo, Davide; Mangialardi, Nicola; Ronchey, Sonia; Fazzini, Stefano; Orrico, Matteo; Barbero, Stefano; Camparini, Stefano; Stabile, Eugenio; Ruotolo, Carlo; Ficarelli, Ilaria; Maritati, Gabriele; Sbenaglia, Giorgio; Passalacqua, Giovanni; Comelli, Simone; Bartolini, Stefano; Siani, Andrea; Accrocca, Federico; Zandrino, Franco; Gallesio, Ivan; Cappelli, Alessandro; Baldi, Claudio; Mele, Mariagnese; Panzano, Claudia; Alba, Giuseppe; Grottola, Gaia; Bisatti, Pela; Brancaccio, Brenda. - In: JMIR RESEARCH PROTOCOLS. - ISSN 1929-0748. - 8:3(2019). [10.2196/resprot.9972]

The Indigo System in acute lower-limb malperfusion (INDIAN) registry. Protocol

Francesco Speziale;Wassim Mansour;Pasqualino Sirignano;Giacomo Isernia;Gioele Simonte;Gianluca Citoni;Andrea Esposito;Stefano Fazzini;Stefano Bartoli;Alessandro Cappelli;
2019

Abstract

Background: Acute lower limb ischemia (ALLI) poses a major threat to limb survival. For many years, surgical thromboembolectomy was the mainstay of treatment. Recent years have brought an endovascular revolution to the management of ALLI. It seems that the newly designed endovascular thrombectomy devices may shift treatment recommendations toward endovascular options. This protocol study aims to collect evidence supporting the latest hypothesis. Objective: The devices under investigation are the Penumbra/Indigo Systems (Penumbra Inc). The objective of this clinical investigation is to evaluate, in a controlled setting, the early safety and effectiveness of the devices and to define the optimal technique for the use of these systems in patients with confirmed peripheral acute occlusions. Methods: This study will be an interventional prospective trial of patients with a diagnosis of ALLI treated with Penumbra/Indigo devices. This project is intended to be a national platform where every physician invited to participate could register his or her own data procedure. The primary outcome is the technical success of thromboaspiration with the Indigo System. Assessment of vessel patency will be recorded using the Thrombolysis in Myocardial Infarction (TIMI) score classifications before and after use of the device. Clinical success at follow-up is defined as an improvement of Rutherford classification at 1-month follow-up of one class or more as compared to the preprocedure Rutherford classification. Secondary endpoints include the following: (1) safety rate at discharge, defined as the absence of any serious adverse events; (2) primary patency at 1 month, defined as a target lesion without a hemodynamically significant stenosis or reocclusion on duplex ultrasound (>50%) and without target lesion reintervention within 1 month; and (3) limb salvage at 1 month. Results: The study is currently in the recruitment phase and the final patient is expected to be treated by the end of March 2019. A total of 150 patients will be recruited. Analyses will focus on primary and secondary endpoints. Conclusions: These new endovascular thrombectomy devices that are specifically designed for peripheral intervention in this difficult set of patients, as those under investigation in the proposed registry, may offer improved clinical outcomes with lower rates of major systemic and local complications. Following completion of this study, it is expected that the value of the Indigo Thrombectomy System in the treatment of ALLI will be better defined. As a result, a shift of treatment recommendations toward endovascular options may be observed in the near future.
File allegati a questo prodotto
File Dimensione Formato  
De-Donato_Indigo- System _2019.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 371.46 kB
Formato Adobe PDF
371.46 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1411283
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact